Cerebral spinal fluid involvement by Hodgkin's disease diagnosed by CSF cytology and immunocytochemistry

L A Perez-Jaffe1, K E Salhany, R J Green

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA.

Insights

Cytologic examination of cerebrospinal fluid (CSF) detected central nervous system (CNS) involvement by Hodgkin's disease (HD) before imaging revealed lesions. This early detection facilitated timely treatment, leading to negative CSF cytology post-therapy.

Area of Science:

  • Hematology
  • Neurology
  • Oncology

Background:

  • Disseminated Hodgkin's disease (HD) poses challenges in detecting central nervous system (CNS) involvement.
  • Autologous bone marrow transplantation is a treatment option for advanced HD.
  • Diplopia in a patient with stage IV HD prompted investigation for CNS involvement.

Observation:

  • Cerebrospinal fluid (CSF) cytology revealed Reed-Sternberg (RS) cells, indicative of HD.
  • Magnetic resonance imaging (MRI) of the brain and spinal cord did not show leptomeningeal disease or intracranial masses.
  • Immunocytochemical stains confirmed the RS cells' phenotype matched the bone marrow biopsy, verifying HD in the CSF.

Findings:

  • Cytologic examination of CSF enabled early detection of CNS involvement by HD.
  • The patient received intrathecal methotrexate post-bone marrow transplant.
  • Subsequent CSF cytology specimens were negative for tumor after treatment.

Implications:

  • CSF cytology is a valuable tool for early diagnosis of CNS involvement in HD.
  • Early detection of CNS HD can guide timely therapeutic interventions.
  • This case highlights the utility of CSF cytology in managing disseminated HD with potential CNS spread.

Related Concept Videos